Annual General Meeting 2021
Annual General Meeting 2021
Optomed’s Annual General Meeting will be held at Life Science Center, Keilaranta 16 B, FI-02150, Espoo, Finland on 28 April 2021.
The Board of Directors of the Company has resolved on extraordinary meeting procedures pursuant to the temporary legislation. Due to the COVID-19 pandemic, the Company has resolved to take actions enabled by the temporary legislation in order to hold the meeting in a predictable manner, taking into account the health and safety of the Company’s shareholders, personnel and other stakeholders. For these reasons, the Annual General Meeting will be held without shareholders’ and their proxy representatives’ presence at the venue of the meeting. Shareholders and their proxy representatives can only participate in the meeting and use shareholders’ rights by voting in advance as well as by posing counterproposals and questions in advance.
Notice of participation and voting in advance
The registration period and advance voting period commence on 8 April 2021 at 10:00 a.m. (EEST) and end on 21 April 2021 at 4:00 p.m. (EEST).
Shareholders who hold at least one hundredth (1/100) of all the shares in the Company have the right to pose counterproposals concerning the matters on the agenda of the Annual General Meeting to be placed for a vote. Such counterproposals shall be delivered to the Company by email to email@example.com at the latest by 6 April 2021 at 4:00 p.m. (EEST), by which time the counterproposals must be received by the Company. The shareholders shall in connection with the counterproposal present a statement of their shareholding in the Company.
A shareholder has the right to pose questions with respect to the matters to be considered at the meeting pursuant to Chapter 5, Section 25 of the Finnish Companies Act by email to firstname.lastname@example.org or by regular mail to Optomed Plc, Life Science Center Keilaniemi, Keilaranta 16 B, FI-02150 Espoo, Finland at the latest by 14 April 2021 at 4:00 p.m. (EEST), by which time the questions must be received by the Company. Such questions by shareholders, responses to such questions by the Company’s management in accordance with the Finnish Companies Act as well as other counterproposals than those put up to a vote are available on the Company’s website at www.optomed.com/investors/annual-general-meeting-2021 on 19 April 2021 at the latest. As a prerequisite for presenting questions or counterproposals, a shareholder must present sufficient evidence to the Company of his/her shareholdings.
Material for the general meeting:
- Invitation that includes the agenda
- The introduction and contact information of the designated proxy representative
- Financial Statements, Report of the Board of Directors and Auditor’s Report
- Remuneration Report for Governing Bodies
- Proposal of the Nomination Board
- CVs of the (proposed) re-elected board members
- CV of a new proposed board member: Xisi Guo
- Privacy Notice
- Proxy form
- Advance voting form